Indefinite Delivery Contract SPE2DB24D9803

The federal contract IDV award SPE2DB24D9803 is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this IDC, DMS Pharmaceutical Group provides an extensive array of medications, including both common and specialized pharmaceutical products, to support the diverse medical requirements of military personnel and their dependents across various Department of Defense (DoD) healthcare facilities. This contract complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites. The IDC was awarded without any set-aside designations under the DLA's SPE2DB program.